Durability of the Tumor-Free Response for Intravesical Bacillus Calmette-Guerin Therapy
Author:
Affiliation:
1. From the Departments of Surgery and Pathology, Washington University School of Medicine, St. Louis, Missouri
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference24 articles.
1. Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors;Morales;J. Urol.,1976
2. Experience with intravesical bacillus Calmette-Guerin therapy of superficial bladder tumors;Herr;Urology,1985
3. Effects of intravesical bacillus Calmette-Guerin (BCG) on carcinoma in situ of the bladder;Herr;Cancer,1983
4. Experience with bacillus Calmette-Guerin in patients with superficial bladder cancer;Brosman;J. Urol.,1982
5. BCG in the management of superficial bladder cancer;Brosman;Urology,1984
Cited by 94 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The effect of intravesical chemohyperthermia with mitomycin in non-muscle-invasive bladder tumour patients who cannot tolerate BCG treatment or recur after treatment and refuse cystectomy;International Urology and Nephrology;2024-07-31
2. HER2 positivity predicts BCG unresponsiveness and adaptive immune cell exhaustion in EORTC risk-stratified cohort of bladder cancer;Frontiers in Immunology;2023-12-08
3. Identification of New Prognostic Markers and Therapeutic Targets for Non-Muscle Invasive Bladder Cancer: HER2 as a Potential Target Antigen;Frontiers in Immunology;2022-05-23
4. Intravesical sequential gemcitabine and docetaxel versus bacillus calmette-guerin (BCG) plus interferon in patients with recurrent non-muscle invasive bladder cancer following a single induction course of BCG;Urologic Oncology: Seminars and Original Investigations;2022-01
5. International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin–exposed High-risk Non–muscle-invasive Bladder Cancer;European Urology;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3